1. Production and identification of iturin A lipopeptide from Bacillus methyltrophicus TEB1 for control of Phoma tracheiphila.
- Author
-
Kalai-Grami L, Karkouch I, Naili O, Slimene IB, Elkahoui S, Zekri RB, Touati I, Mnari-Hattab M, Hajlaoui MR, and Limam F
- Subjects
- Ascomycota drug effects, Bacillus genetics, Lipopeptides biosynthesis, Lipopeptides pharmacology, Mass Spectrometry, Microbial Sensitivity Tests, Mycelium drug effects, Peptides, Cyclic biosynthesis, Antifungal Agents pharmacology, Ascomycota growth & development, Bacillus metabolism, Biological Control Agents pharmacology, Mycelium growth & development, Peptides, Cyclic pharmacology, Plant Diseases microbiology, Spores, Fungal drug effects
- Abstract
A lipopeptide-producing endophytic Bacillus methyltrophicus TEB1 strain exhibited potent antifungal activity against Phoma tracheiphila. Lipopeptide production started at the early growth phase plateaued after 36 h of culture where it reduced the mycelium growth by 80%. The crude lipopeptide extract harvested at the stationary phase efficiently inhibited the growth of P. tracheiphila mycelium and MIC values displaying 50 and 90% inhibition of conidia germination were around 47.5 and 100 μg ml(-1) , respectively. Increasing lipopeptide extract till 3 mg ml(-1) induced 10% swelling and 3% crumbling of P. tracheiphila conidia whereas 5 mg ml(-1) induced 40% swelling and 20% crumbling. Mass spectrometry analysis of the lipopeptide extract indicated that surfactin production took place from 12 to 20 h, iturin A from 16 to 72 h, and fengycin from 12 to 72 h and that the main active compound against P. tracheiphila was identified as C15 iturin A lipopeptide. Iturin A appeared as a potential biological control agent able to substitute the currently used chemical pesticides in agriculture., (© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.)
- Published
- 2016
- Full Text
- View/download PDF